NO860848L - Fremgangsm¨te ved fremstilling av gammaglobulin som er egn et for intraven¯s administrering. - Google Patents

Fremgangsm¨te ved fremstilling av gammaglobulin som er egn et for intraven¯s administrering.

Info

Publication number
NO860848L
NO860848L NO860848A NO860848A NO860848L NO 860848 L NO860848 L NO 860848L NO 860848 A NO860848 A NO 860848A NO 860848 A NO860848 A NO 860848A NO 860848 L NO860848 L NO 860848L
Authority
NO
Norway
Prior art keywords
concn
ppte
sepd
impure
prod
Prior art date
Application number
NO860848A
Other languages
English (en)
Other versions
NO168943C (no
NO168943B (no
Inventor
Juergen-Dietrich Fried Fiechtl
Bernhard Kerner
Juergen Holzapfel
Martin Puschmann
Tokusuke Kimura
Fumio Kurosu
Original Assignee
Woelm Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Woelm Pharma Gmbh & Co filed Critical Woelm Pharma Gmbh & Co
Publication of NO860848L publication Critical patent/NO860848L/no
Publication of NO168943B publication Critical patent/NO168943B/no
Publication of NO168943C publication Critical patent/NO168943C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO86860848A 1984-07-07 1986-03-06 Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering NO168943C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP84107985A EP0168506B2 (en) 1984-07-07 1984-07-07 Process for preparing gamma globulin suitable for intravenous administration
PCT/EP1985/000320 WO1986000530A1 (en) 1984-07-07 1985-07-03 Process for preparing gamma globulin suitable for intravenous administration
JP7263622A JPH08319241A (ja) 1984-07-07 1995-09-19 静脈注射用ガンマグロブリン組成物

Publications (3)

Publication Number Publication Date
NO860848L true NO860848L (no) 1986-03-06
NO168943B NO168943B (no) 1992-01-13
NO168943C NO168943C (no) 1992-04-22

Family

ID=26091956

Family Applications (1)

Application Number Title Priority Date Filing Date
NO86860848A NO168943C (no) 1984-07-07 1986-03-06 Fremgangsmaate ved fremstilling av gammaglobulin som er egnet for intravenoes administrering

Country Status (8)

Country Link
EP (1) EP0168506B2 (no)
JP (2) JPH0816065B2 (no)
AT (1) ATE59144T1 (no)
DE (1) DE3483784D1 (no)
DK (1) DK164023C (no)
FI (1) FI84136C (no)
NO (1) NO168943C (no)
WO (1) WO1986000530A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
BR112014004445B1 (pt) 2011-08-26 2022-11-22 Takeda Pharmaceutical Company Limited Método para reduzir conteúdo de fator xi e/ou fator xia em uma composição de imunoglobulina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
DE3173666D1 (en) * 1981-10-29 1986-03-13 Green Cross Corp Process for preparing immunoglobulin suitable for intravenous injection

Also Published As

Publication number Publication date
DK164023C (da) 1992-09-28
WO1986000530A1 (en) 1986-01-30
JPH0816065B2 (ja) 1996-02-21
FI84136B (fi) 1991-07-15
DE3483784D1 (de) 1991-01-31
FI860350A0 (fi) 1986-01-24
NO168943C (no) 1992-04-22
FI860350A (fi) 1986-01-24
DK97286D0 (da) 1986-03-04
DK97286A (da) 1986-03-04
JPH08319241A (ja) 1996-12-03
NO168943B (no) 1992-01-13
FI84136C (fi) 1991-10-25
EP0168506B2 (en) 1998-01-07
ATE59144T1 (de) 1991-01-15
JPS61500972A (ja) 1986-05-15
DK164023B (da) 1992-05-04
EP0168506A1 (en) 1986-01-22
EP0168506B1 (en) 1990-12-19

Similar Documents

Publication Publication Date Title
John et al. Adaptation of the gastric mucosa to repeated administration of aspirin in the rat
Miller et al. Liver injury, liver protection, and sulfur metabolism: methionine protects against chloroform liver injury even when given after anesthesia
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
Pesanti et al. Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage.
AU573866B2 (en) Composition containing xanthine derivatives and o-acetylsalicylic acid
Boyland et al. Enzyme activity in relation to cancer: inhibition of urinary β-glucuronidase of patients with cancer of the bladder by oral administration of 1: 4-saccharolactone and related compounds
NO860848L (no) Fremgangsm¨te ved fremstilling av gammaglobulin som er egn et for intraven¯s administrering.
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
Welsh et al. Heat-shock treatment of mouse pancreatic islets results in a partial loss of islet cells but no remaining functional impairment among the surviving β cells
Caygill et al. Presence of glucosaminidase activity in human synovial fluid and its inhibition by gold compounds
Golub et al. The inhibition of the maturation of newly synthesized bone collagen by β-aminopropionitrile in tissue culture
Toom et al. Cardiac effects of Stomolophus meleagris (cabbage head jellyfish) toxin
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
Moav et al. Activation of the fibrinolytic system of the guinea pig following inoculation of Echis colorata venom
Waelsch et al. On the Toxicity of Atabrine.
Lowenthal et al. The Inhibition of Hyaluronidase by Sodium Salicylate and Its Possible Metabolites
Chiang et al. Collagen-platelet interaction: Type XI collagen-induced platelet aggregation
Wanner et al. Urinary proteinase activity in patients with multiple traumatic injuries, sepsis, or acute renal failure
Li et al. Effects of heparin on hepatic regeneration and function after partial hepatectomy in rats
SU1676628A1 (ru) Противоалкогольное средство "Гликал
McCulloch Demonstration of incomplete Rh-antibodies by alpha-globulin
Nellas et al. Pancreatic collagenase therapy for severe, progressive systemic sclerosis: Effect on skin and on hydroxyproline content in urine
Bornstein et al. Effect of thioctic acid on glucose oxidation by liver slices
Hudock et al. Gastric control of pancreatic secretion: an experimental study
Carstens et al. The soluble, cyclic AMP-stimulated protein kinase catalyses the phosphorylation of different membrane proteins from those which are phosphorylated by the membrane bound enzyme